SNPs in DNA repair or oxidative stress genes and late subcutaneous fibrosis in patients following single shot partial breast irradiation

Journal of Experimental and Clinical Cancer Research

Volumn 31, Issue 1, 2012, Pages

  Falvo, Elisabetta ^a   Strigari, Lidia ^a   Citro, Gennaro ^a   Giordano, Carolina ^a   Boboc, Genoveva ^a   Fabretti, Fabiana ^a   Bruzzaniti, Vicente ^a   Bellesi, Luca ^a   Muti, Paola ^b,c   Blandino, Giovanni ^a   Pinnar, Paola ^a  

^a REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^b MCMASTER UNIVERSITY   (Canada)

^c HARVARD UNIVERSITY   (United States)

Author keywords

Breast cancer; Fibrosis; Late effects; Polymorphisms; Radiotherapy

Indexed keywords

GLUTATHIONE TRANSFERASE; RAD51 PROTEIN; REACTIVE OXYGEN METABOLITE; XRCC1 PROTEIN; XRCC3 PROTEIN; DNA BINDING PROTEIN; GONAD SPECIFIC TRANSPORTER, HUMAN; GONAD-SPECIFIC TRANSPORTER, HUMAN; ORGANIC ANION TRANSPORTER; X-RAY REPAIR CROSS COMPLEMENTING PROTEIN 1; X-RAY REPAIR CROSS COMPLEMENTING PROTEIN 3;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER RADIOTHERAPY; DNA REPAIR; ERYTHEMA; FAT NECROSIS; FEMALE; FIBROSIS; FOLLOW UP; GENE FREQUENCY; GENETIC RISK; HUMAN; MAJOR CLINICAL STUDY; MARKER GENE; OXIDATIVE STRESS; PREDICTION; PRIORITY JOURNAL; RADIATION INJURY; SINGLE NUCLEOTIDE POLYMORPHISM; SINGLE SHOT PARTIAL BREAST IRRADIATION; BREAST TUMOR; CLINICAL TRIAL; GENETIC ASSOCIATION; GENETICS; MIDDLE AGED; PATHOLOGY; RADIATION EXPOSURE; RADIOTHERAPY;

AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; DNA REPAIR; DNA-BINDING PROTEINS; FEMALE; FIBROSIS; FOLLOW-UP STUDIES; GENETIC ASSOCIATION STUDIES; HUMANS; MIDDLE AGED; ORGANIC ANION TRANSPORTERS; OXIDATIVE STRESS; POLYMORPHISM, SINGLE NUCLEOTIDE; RAD51 RECOMBINASE; RADIOTHERAPY;

EID: 84856068328     PISSN: None     EISSN: 17569966     Source Type: Journal    
DOI: 10.1186/1756-9966-31-7     Document Type: Article

References (58)

1. Radiotherapy after breast-conserving surgery in small breast carcinoma: long-term results of a randomized trial. Veronesi U, Marubini E, Mariani L, Galimberti V, Luini A, Veronesi P, Salvadori B, Zucali R, Ann Oncol 2001 12 997 1003 10.1023/A:1011136326943 11521809 (Pubitemid 32725776)
2. Ipsilateral breast tumor recurrence and survival following lumpectomy and irradiation: pathological findings from NSABP protocol B-06. Fisher ER, Anderson S, Redmond C, Fisher B, Semin Surg Oncol 1992 8 161 166 1496227
3. Radiotherapy after breast-preserving surgery in women with localized cancer of the breast. Veronesi U, Luini A, Del Vecchio M, Greco M, Galimberti V, Merson M, Rilke F, Sacchini V, Saccozzi R, Savio T, et al. N Engl J Med 1993 328 1587 1591 10.1056/NEJM199306033282202 8387637 (Pubitemid 23151918)
4. Accelerated partial breast irradiation as a part of breast conservation therapy. Arthur DW, Vicini FA, J Clin Oncol 2005 23 1726 1735 10.1200/JCO.2005.09.045 15755981 (Pubitemid 46211425)
5. Accelerated hypofractionated radiotherapy as adjuvant regimen after conserving surgery for early breast cancer: interim report of toxicity after a minimum follow up of 3 years. Pinnar P, Soriani A, Landoni V, Giordano C, Papale M, Marsella A, Marucci L, Arcangeli G, Strigari L, J Exp Clin Cancer Res 2010 29 9 10.1186/1756-9966-29-9 20100335
6. Reports of unexpected late side effects of accelerated partial breast irradiation - radiobiological considerations. Bentzen SM, Yarnold JR, Int J Radiat Oncol Biol Phys 2010 77 969 973 10.1016/j.ijrobp.2010.01.059 20610037
7. Toxicity of three-dimensional conformal radiotherapy for accelerated partial breast irradiation. Hepel JT, Tokita M, MacAusland SG, et al. Int J Radiat Oncol Biol Phys 2009 75 1290 1296 10.1016/j.ijrobp.2009.01.009 19395195
8. Toxicity and cosmesis outcomes after single fraction partial breast irradiation in early stage breast cancer. Pinnar P, Arcangeli S, Giordano C, Arcangeli G, Impiombato FA, Pinzi V, Iaccarino G, Soriani A, Landoni V, Strigari L, Radiat Oncol 2011 6 155 10.1186/1748-717X-6-155 22079051
9. The radiotherapeutic injury - a complex 'wound'. Denham JW, Hauer-Jensen M, Radiother Oncol 2002 63 129 145 10.1016/S0167-8140(02)00060-9 12063002 (Pubitemid 34628401)
10. Free radicals in biology: oxidative stress and the effects of ionizing irradiation. Riley P, Int J Radiat Biol 1994 65 27 33 10.1080/09553009414550041 7905906 (Pubitemid 24063526)
11. Germline glutathione S-transferase variants in breast cancer: relation to diagnosis and cutaneous long-term adverse effects after two fractionation patterns of radiotherapy. Edvardsen H, Kristensen VN, Grenaker Alnaes GI, Bøhn M, Erikstein B, Helland A, Børresen-Dale AL, Fosså SD, Int J Radiat Oncol Biol Phys 2007 67 1163 1171 10.1016/j.ijrobp.2006.11.009 17336217
12. Preventing or reducing late side effects of radiation therapy: radiobiology meets molecular pathology. Bentzen SM, Nat Rev Cancer 2006 6 702 713 10.1038/nrc1950 16929324 (Pubitemid 44286002)
13. Glutathione S-transferase p elicits protection against H2O2-induced cell death via coordinated regulation of stress kinases. Yin Z, Ivanov VN, Habelhah H, Tew K, Ronai Z, Cancer Res 2000 60 4053 4057 10945608 (Pubitemid 30636583)
14. Activation of the antioxidant enzyme 1-CYS peroxiredoxin requires glutathionylation mediated by heterodimerization with pi GST. Manevich Y, Feinstein SI, Fisher AB, Proc Natl Acad Sci USA 2004 101 3780 3785 10.1073/pnas.0400181101 15004285 (Pubitemid 38381055)
15. Human glutathione S-transferase P1-1 interacts with TRAF2 and regulates TRAF2-ASK1 signals. Wu Y, Fan Y, Xue B, Luo L, Shen J, Zhang S, Jiang Y, Yin Z, Oncogene 2006 25 5787 5800 10.1038/sj.onc.1209576 16636664 (Pubitemid 44435255)
16. Genetic predictors of acute toxicitiesrelated to radiation therapy following lump ectomy for breast cancer: a case-series study. Ambrosone CB, Tian C, Ahn J, Kropp S, Helmbold I, von Fournier D, Haase W, Sautter-Bihl ML, Wenz F, Chang-Claude J, Breast Cancer Res 2006 8 40 10.1186/bcr1526 16848913 (Pubitemid 44111650)
17. Genome maintenance mechanisms for preventing cancer. Hoeijmakers JH, Nature 2001 411 366 374 10.1038/35077232 11357144 (Pubitemid 32467046)
18. Radiation-induced DNA damage responses. Jeggo P, Lobrich M, Radiat Prot Dosim 2006 122 124 127 (Pubitemid 47090437)
19. Genetic variations in DNA repair genes, radiosensitivity to cancer and susceptibility to acute tissue reactions in radiotherapy-treated cancer patients. Chistiakov DA, Voronova NV, Chistiakov PA, Acta Oncologica 2008 47 809 824 10.1080/02841860801885969 18568480 (Pubitemid 351882749)
20. Polymorphisms in the DNA Repair Gene XRCC1, Breast Cancer Risk, and Response to Radiotherapy. Moullan N, Cox DG, Angele S, Romestaing P, Gerard JP, Hall J, Cancer Epidemiol Biomarkers Prev 2003 12 1168 1174 14652276 (Pubitemid 37499439)
21. Association between genetic polymorphisms in the XRCC1, XRCC3, XPD, GSTM1, GSTT1, MSH2, MLH1, MSH3, and MGMT genes and radiosensitivity in breast cancer patients. Mango Mangoni M, Bisanzi S, Carozzi F, Sani C, Biti G, Livi L, Barletta E, Costantini AS, Gorini G, Int J Radiat Oncol Biol Phys 2011 81 52 58 10.1016/j.ijrobp.2010.04.023 20708344
22. Genetic polymorphisms in the DNA double-strand break repair genes XRCC3, XRCC2, and NBS1 are not associated with acute side effects of radiotherapy in breast cancer patients. Popanda O, Tan XL, Ambrosone CB, Kropp S, Helmbold I, von Fournier D, Haase W, Sautter-Bihl ML, Wenz F, Schmezer P, Chang-Claude J, Cancer Epidemiol Biomarkers Prev 2006 15 1048 1050 10.1158/1055-9965.EPI-06-0046 16702393 (Pubitemid 43823540)
23. Association between polymorphisms in the DNA repair genes,XRCC1, APE1, and XPD and acute side effects of radiotherapy in breast cancer patients. Chang-Claude J, Popanda O, Tan XL, Kropp S, Helmbold I, von Fournier D, Haase W, Sautter-Bihl ML, Wenz F, Schmezer P, Ambrosone CB, Clin Cancer Res 2005 11 4802 4809 10.1158/1078-0432.CCR-04-2657 16000577 (Pubitemid 41557201)
24. Genetic susceptibility to late normal tissue injury. Travis EL, Semin Radiat Oncol 2007 17 14
25. Radiation reaction in ataxia telangiectasia. Morgan JL, Holcomb TM, Morrissey RW, Am J Dis Child 1968 116 557 558 5687489
26. Single fraction partial breast irradiation in prone position. Iaccarino G, Pinnaro P, Landoni V, Marzi S, Soriani A, Giordano C, Arcangeli S, Benassi M, Arcangeli G, J Exp Clin Cancer Res 2007 26 543 552 18365551 (Pubitemid 351157873)
27. IsoBED: a tool for automatic calculation of biologically equivalent fractionation schedules in radiotherapy using IMRT with a simultaneous integrated boost (SIB) technique. Bruzzaniti V, Abate A, Pedrini M, Benassi M, Strigari L, J Exp Clin Cancer Res 2011 30 52 10.1186/1756-9966-30-52 21554675
28. The time factor in oncology: consequences on tumour volume and therapeutic planning. Creton G, Benassi M, Di Staso M, Ingrosso G, Giubilei C, Strigari L, J Exp Clin Cancer Res 2006 25 557 573 17310848 (Pubitemid 46166771)
29. Influence of time interval between surgery and radiotherapy on tumor regrowth. Cividalli A, Creton G, Ceciarelli F, Strigari L, Tirindelli Danesi D, Benassi M, J Exp Clin Cancer Res 2005 24 109 116 15943040 (Pubitemid 40655871)
30. A heterogeneous dose distribution in simultaneous integrated boost: the role of the clonogenic cell density on the tumor control probability. Strigari L, D'Andrea M, Abate A, Benassi M, Phys Med Biol 2008 7 5257 5273
31. CTCAE, version 3.0. http://ctep.cancer.gov/protocoldevelopment/ electronic-applications/docs/ctcaev3.pdf
32. Fat necrosis after partial-breast irradiation with brachytherapy or electron irradiation versus standard whole-breast radiotherapy: 4-year results of a randomized trial. Lövely K, Fodor J, Major T, Szabá E, Orosz Z, Sulyok Z, Jánváry L, Fröhlich G, Kásler M, Polgár C, Int J Radiat Oncol Biol Phys 2007 69 724 731 10.1016/j.ijrobp.2007.03.055 17524571 (Pubitemid 47418393)
33. Pyrosequencing of clinically relevant polymorphisms. Marsh S, King CR, Garsa AA, McLeod HL, Methods Mol Biol 2005 311 97 114 16100402
34. Dose and polymorphic genes xrcc1, xrcc3, gst play a role in the risk of developing erythema in breast cancer patients following single shot partial breast irradiation after conservative surgery. Falvo E, Strigari L, Citro G, Giordano C, Arcangeli S, Soriani A, D'Alessio D, Muti P, Blandino G, Sperduti I, Pinnar P, BMC Cancer 2011 11 291 10.1186/1471-2407-11-291 21749698
35. Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881-10882 trial. Bartelink H, Horiot JC, Poortmans PM, Struikmans H, Van den Bogaert W, Fourquet A, Jager JJ, Hoogenraad WJ, Oei SB, Wárlám-Rodenhuis CC, Pierart M, Collette L, J Clin Oncol 2007 25 3259 3265 10.1200/JCO.2007.11.4991 17577015 (Pubitemid 47325610)
36. Identification of SNPs associated with susceptibility for development of adverse reactions to radiotherapy. Rosenstein BS, Pharmacogenomics 2011 12 267 275 10.2217/pgs.10.186 21332318
37. Effector peptides from glutathione-S-transferase-pi affect the activation of jun by jun-N-terminal kinase. Adler V, Pincus MR, Ann Clin Lab Sci 2004 34 35 46 15038666 (Pubitemid 38280302)
38. Differential effects of glutathione S-transferase pi (GSTP1) haplotypes on cell proliferation and apoptosis. Holley SL, Fryer AA, Haycock JW, Grubb SE, Strange RC, Hoban PR, Carcinogenesis 2007 11 2268 2273 (Pubitemid 350111584)
39. Association of single nucleotide polymorphisms in ATM, GSTP1, SOD2, TGFB1, XPD and XRCC1 with clinical and cellular radiosensitivity. Zschenker O, Raabe A, Boeckelmann IK, Borstelmann S, Szymczak S, Wellek S, Rades D, Hoeller U, Ziegler A, Dikomey E, Borgmann K, Radiother Oncol 2010 97 26 32 10.1016/j.radonc.2010.01.016 20170971
40. Genetic predictors of long-term toxicities after radiation therapy for breast cancer. Kuptsova N, Chang-Claude J, Kropp S, Helmbold I, Schmezer P, von Fournier D, Haase W, Sautter-Bihl ML, Wenz F, Onel K, Ambrosone CB, Int J Cancer 2008 122 1333 1339 18027873 (Pubitemid 351287234)
41. S-glutathionylation: indicator of cell stress and regulator of the unfolded protein response. Townsend DM, Mol Interv 2007 7 313 324 10.1124/mi.7.6.7 18199853
42. Preventing or reducing late side effects of radiation therapy: radiobiology meets molecular pathology. Bentzen SM, Nat Rev Cancer 2006 6 702 713 10.1038/nrc1950 16929324 (Pubitemid 44286002)
43. Temporal modulation of TGF-beta 1 and beta-actin gene expression in pig skin and muscular fibrosis after ionizing radiation. Martin M, Lefaix JL, Pinton P, Crechet F, Daburon F, Radiat Res 1993 134 63 70 10.2307/3578502 8475255 (Pubitemid 23157426)
44. Late radiation-related fibrosis: pathogenesis, manifestations, and current management. O'Sullivan B, Levin W, Semin Radiat Oncol 2003 13 274 289 10.1016/S1053-4296(03)00037-7 12903016 (Pubitemid 36962650)
45. Oxidative damage pathways in relation to normal tissue injury. Zhao W, Diz DI, Robbins ME, Br J Radiol 2007 80 23 31 10.1259/bjr/18237646 (Pubitemid 47517796)
46. GST function in drug and stress response. Tew KD, Ronai Z, Drug Resist Updat 1999 2 143 147 10.1054/drup.1999.0086 11504484 (Pubitemid 29398149)
47. Coactivation of AP-1 activity and TGF-b1 gene expression in the stress response of normal skin cells to ionizing radiation. Martin M, Vozenin MC, Gault N, Crechet F, Pfarr CM, Lefaix JL, Oncogene 1997 15 981 989 10.1038/sj.onc.1201433 9285693 (Pubitemid 27399559)
48. Does variability in normal tissue reactions after radiotherapy have a genetic basis-where and how to look for it? Andreassen CN, Alsner J, Overgaard J, Radiother Oncol 2002 64 131 140 10.1016/S0167-8140(02)00154-8 12242122 (Pubitemid 35247890)
49. The genomics revolution and radiotherapy. West CM, Elliott RM, Burnet NG, Clin Oncol 2007 19 470 480 10.1016/j.clon.2007.02.016 (Pubitemid 46995613)
50. Is clinical radiosensitivity a complex genetically controlled event? Filippi AR, Franco P, Ricardi U, Tumori 2006 92 87 91 16724685 (Pubitemid 43835965)
51. Risk of radiation-induced subcutaneous fibrosis in relation to single nucleotide polymorphisms in TGFB1, SOD2, XRCC1, XRCC3, APEX and ATM-a study based on DNA from formalin fixed paraffin embedded tissue samples. Andreassen CN, Alsner J, Overgaard M, Sorensen FB, Overgaard J, Int J Radiat Biol 2006 82 577 586 10.1080/09553000600876637 16966185 (Pubitemid 44373575)
52. TGFB1 polymorphisms are associated with risk of late normal tissue complications in the breast after radiotherapy for early breast cancer. Andreassen CN, Alsner J, Overgaard J, Herskind C, Haviland J, Owen R, Homewood J, Bliss J, Yarnold J, Radiother Oncol 2005 75 18 21 10.1016/j.radonc.2004.12. 012 15878096 (Pubitemid 40616789)
53. Genetic polymorphisms in DNA repair and damage response genes and late normal tissue complications of radiotherapy for breast cancer. Chang-Claude J, Ambrosone CB, Lilla C, Kropp S, Helmbold I, von Fournier D, Haase W, Sautter-Bihl ML, Wenz F, Schmezer P, Popanda O, Br J Cancer 2009 100 1680 1686 10.1038/sj.bjc.6605036 19367277
54. Association between normal tissue complications after radiotherapy and polymorphic variations in TGFB1 and XRCC1 genes. Alsbeih G, Al-Harbi N, Al-Hadyan K, El-Sebaie M, Al-Rajhi N, Radiat Res 2010 173 505 511 10.1667/RR1769.1 20334523
55. Prediction of normal tissue radiosensitivity from polymorphisms in candidate genes. Andreassen CN, Alsner J, Overgaard M, Overgaard J, Radiother Oncol 2003 69 127 135 10.1016/j.radonc.2003.09.010 14643949 (Pubitemid 37485871)
56. Association of DNA repair and steroid metabolism gene polymorphisms with clinical late toxicity in patients treated with conformal radiotherapy for prostate cancer. Damaraju S, Murray D, Dufour J, et al. Clin Cancer Res 2006 12 2545 2554 10.1158/1078-0432.CCR-05-2703 16638864
57. The late radiotherapy normal tissue injury phenotypes of telangiectasia, fibrosis and atrophy in breast cancer patients have distinct genotype-dependent causes. Giotopoulos G, Symonds RP, Foweraker K, Griffin M, Peat I, Osman A, Plumb M, Br J Cancer 2007 96 1001 1007 10.1038/sj.bjc.6603637 17325707 (Pubitemid 46452279)
58. Functional Polymorphisms of Base Excision Repair Genes XRCC1 and APEX1 Predict Risk of Radiation Pneumonitis in Patients with Non-Small Cell Lung Cancer Treated with Definitive Radiation Therapy. Yin M, Liao Z, Liu Z, Wang LE, Gomez D, Komaki R, Wei Q, Int J Radiat Oncol Biol Phys 2011 81 67 e73 10.1016/j.ijrobp.2010.11.079 21420246